KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biogen (BIIB) Inventory Average (2016 - 2026)

Biogen has reported Inventory Average over the past 18 years, most recently at $2.1 billion for Q1 2026.

  • For Q1 2026, Inventory Average fell 13.04% year-over-year to $2.1 billion; the TTM value through Mar 2026 reached $2.1 billion, down 13.04%, while the annual FY2025 figure was $2.3 billion, 7.2% down from the prior year.
  • Inventory Average for Q1 2026 was $2.1 billion at Biogen, down from $2.2 billion in the prior quarter.
  • Over five years, Inventory Average peaked at $2.8 billion in Q4 2023 and troughed at $1.3 billion in Q2 2022.
  • A 5-year average of $2.0 billion and a median of $2.2 billion in 2025 define the central range for Inventory Average.
  • Biggest five-year swings in Inventory Average: skyrocketed 102.61% in 2023 and later fell 13.04% in 2026.
  • Year by year, Inventory Average stood at $1.4 billion in 2022, then soared by 102.61% to $2.8 billion in 2023, then decreased by 10.53% to $2.5 billion in 2024, then dropped by 11.2% to $2.2 billion in 2025, then fell by 5.95% to $2.1 billion in 2026.
  • Business Quant data shows Inventory Average for BIIB at $2.1 billion in Q1 2026, $2.2 billion in Q4 2025, and $2.2 billion in Q3 2025.